Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.21.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
REVENUES
OPERATING EXPENSES FROM CONTINUED OPERATIONS    
Payroll and related expenses 76,388 200,279
Professional fees 769,497 75,224
General and administrative 2,414,018 83,379
Research and development expenses 73,954
Total Operating Expenses 3,333,857 358,882
LOSS FROM CONTINUING OPERATIONS 3,333,857 358,882
OTHER INCOME (EXPENSE) FROM CONTINUING OPERATIONS    
Financing costs including interest (37,629) (132,358)
Change in fair value of convertible bridge notes 31,357
Gain on sale of equity method investment 100,000
Loss on debentures and accrued expenses converted to common stock (390,068)
Loss on conversion of bridge notes and accrued interest (744,505)
Total Other Expense, net (1,072,202) (101,001)
Loss from continuing operations before income taxes (4,406,059) (459,883)
INCOME TAXES
Loss from continuing operations (4,406,059) (459,883)
DISCONTINUED OPERATIONS:    
Income from discontinued operations before income taxes 22,481
INCOME TAXES
Income from discontinued operations 22,481
NET LOSS (4,406,059) (437,402)
Series A preferred stock contractual dividends (7,899) (8,317)
Deemed dividend on conversion of Series A preferred stock to shares of common stock (542,500)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (4,956,458) $ (445,719)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC AND DILUTED:    
CONTINUING OPERATIONS $ (0.22) $ (0.20)
DISCONTINUED OPERATIONS 0.01
Earnings Per Share, Basic and Diluted $ (0.22) $ (0.19)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: BASIC AND DILUTED 22,626,906 2,244,343